Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

OTC switch recommended for Nasalcrom

Oct. 18, 1996

Respiratory drugs in Fujisawa's product pipeline

Oct. 11, 1996

Respiratory R&D at Yamanouchi

Oct. 11, 1996

Approval of Pulmozyme recommended for new indication

Oct. 11, 1996

Treatment for cystic fibrosis patients progresses on schedule

Oct. 11, 1996

Dual thromboxane synthase/lipoxygenase inhibitors from Nikken Chemicals

Oct. 11, 1996

New antihistamine for pediatric patients in the U.S.

Oct. 11, 1996

HLE inhibitors described by Zeneca

Oct. 4, 1996

Medeva terminates agreement with Chiesi related to dry powder inhaler

Oct. 4, 1996

Spotlight on LTD4 antagonists

Oct. 4, 1996